v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Private Placement
Preferred Stock
Common Stock
Common Stock
Private Placement
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2024     427 3,000,788          
Beginning balance at Dec. 31, 2024 $ 25,759,776   $ 4 $ 267,679   $ 169,156,374   $ (143,382,122) $ (282,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based Compensation 411,390         411,390      
Issuance of common stock from warrant exercises (in shares)       389,634          
Issuance of Common Stock from Warrant Exercises 265,360     $ 3,896   261,464      
Issuance of Common Stock from Restricted Stock Awards (in shares)       43,069          
Issuance of Common Stock from Restricted Stock Awards 0     $ 431   (431)      
Unrealized Loss on Marketable Securities (27,215)               (27,215)
Foreign Currency Translation Adjustment 63,604               63,604
Net Loss (4,345,439)             (4,345,439)  
Ending balance (in shares) at Jun. 30, 2025     427 3,433,491          
Ending balance at Jun. 30, 2025 22,127,476   $ 4 $ 272,006   169,828,797   (147,727,561) (245,770)
Beginning balance (in shares) at Dec. 31, 2024     427 3,000,788          
Beginning balance at Dec. 31, 2024 25,759,776   $ 4 $ 267,679   169,156,374   (143,382,122) (282,159)
Ending balance (in shares) at Dec. 31, 2025     427 3,761,739          
Ending balance at Dec. 31, 2025 16,126,536   $ 4 $ 275,289   170,314,656   (154,217,276) (246,136)
Beginning balance (in shares) at Mar. 31, 2025     427 3,000,788          
Beginning balance at Mar. 31, 2025 23,700,385   $ 4 $ 267,679   169,304,990   (145,575,102) (297,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based Compensation 262,774         262,774      
Issuance of common stock from warrant exercises (in shares)       389,634          
Issuance of Common Stock from Warrant Exercises 265,360     $ 3,896   261,464      
Issuance of Common Stock from Restricted Stock Awards (in shares)       43,069          
Issuance of Common Stock from Restricted Stock Awards 0     $ 431   (431)      
Unrealized Loss on Marketable Securities (11,116)               (11,116)
Foreign Currency Translation Adjustment 62,532               62,532
Net Loss (2,152,459)             (2,152,459)  
Ending balance (in shares) at Jun. 30, 2025     427 3,433,491          
Ending balance at Jun. 30, 2025 22,127,476   $ 4 $ 272,006   169,828,797   (147,727,561) (245,770)
Beginning balance (in shares) at Dec. 31, 2025     427 3,761,739          
Beginning balance at Dec. 31, 2025 16,126,536   $ 4 $ 275,289   170,314,656   (154,217,276) (246,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based Compensation 318,820         318,820      
Shares Withheld for Employee Taxes on Vested Restricted Stock (in shares)       (5,273)          
Shares Withheld for Employee Taxes on Vested Restricted Stock (10,328)     $ (53)   (10,276)      
Issuance of Common Stock and Warrants from Private Placement, Net of Offering Costs of $72 thousand (in shares)         438,471        
Issuance of Common Stock and Warrants from Private Placement, Net of Offering Costs of $72 thousand   $ 4,928,147     $ 4,385   $ 4,923,762    
Issuance of common stock from warrant exercises (in shares)       188,889          
Issuance of Common Stock from Warrant Exercises 170     $ 1,889   (1,719)      
Issuance of Common Stock from Restricted Stock Awards (in shares)       43,341          
Issuance of Common Stock from Restricted Stock Awards 0     $ 433   (433)      
Unrealized Loss on Marketable Securities (19,336)               (19,336)
Foreign Currency Translation Adjustment 9,674               9,674
Net Loss (4,496,994)             (4,496,994)  
Ending balance (in shares) at Jun. 30, 2026     427 4,427,167          
Ending balance at Jun. 30, 2026 16,856,689   $ 4 $ 281,943   175,544,810   (158,714,270) (255,798)
Beginning balance (in shares) at Mar. 31, 2026     427 3,993,469          
Beginning balance at Mar. 31, 2026 13,934,561   $ 4 $ 277,606   170,521,007   (156,635,260) (228,796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based Compensation 109,310         109,310      
Shares Withheld for Employee Taxes on Vested Restricted Stock (in shares)       (4,773)          
Shares Withheld for Employee Taxes on Vested Restricted Stock (9,317)     $ (48)   (9,269)      
Issuance of Common Stock and Warrants from Private Placement, Net of Offering Costs of $72 thousand (in shares)         438,471        
Issuance of Common Stock and Warrants from Private Placement, Net of Offering Costs of $72 thousand   $ 4,928,147     $ 4,385   $ 4,923,762    
Unrealized Loss on Marketable Securities (10,983)               (10,983)
Foreign Currency Translation Adjustment (16,019)               (16,019)
Net Loss (2,079,010)             (2,079,010)  
Ending balance (in shares) at Jun. 30, 2026     427 4,427,167          
Ending balance at Jun. 30, 2026 $ 16,856,689   $ 4 $ 281,943   $ 175,544,810   $ (158,714,270) $ (255,798)